Solid Biosciences (SLDB) Total Liabilities (2017 - 2024)
Historic Total Liabilities for Solid Biosciences (SLDB) over the last 8 years, with Q3 2024 value amounting to $44.8 million.
- Solid Biosciences' Total Liabilities rose 1099.17% to $44.8 million in Q3 2024 from the same period last year, while for Sep 2024 it was $44.8 million, marking a year-over-year increase of 1099.17%. This contributed to the annual value of $38.5 million for FY2023, which is 2084.55% down from last year.
- As of Q3 2024, Solid Biosciences' Total Liabilities stood at $44.8 million, which was up 1099.17% from $37.7 million recorded in Q2 2024.
- In the past 5 years, Solid Biosciences' Total Liabilities registered a high of $48.6 million during Q4 2022, and its lowest value of $17.2 million during Q2 2020.
- For the 5-year period, Solid Biosciences' Total Liabilities averaged around $34.0 million, with its median value being $38.0 million (2024).
- As far as peak fluctuations go, Solid Biosciences' Total Liabilities plummeted by 3815.98% in 2021, and later surged by 10776.14% in 2023.
- Solid Biosciences' Total Liabilities (Quarter) stood at $39.1 million in 2020, then crashed by 38.16% to $24.2 million in 2021, then skyrocketed by 101.03% to $48.6 million in 2022, then dropped by 20.85% to $38.5 million in 2023, then grew by 16.5% to $44.8 million in 2024.
- Its Total Liabilities was $44.8 million in Q3 2024, compared to $37.7 million in Q2 2024 and $38.0 million in Q1 2024.